STOCK TITAN

[SCHEDULE 13G/A] Spectral AI, Inc. Warrants SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Spectral AI, Inc. received a Schedule 13G/A reporting that Laurence E. Hirsch, Highlander Partners, L.P. and Highlander Partners GP, LLC each beneficially own 900,000 shares of the issuer's common stock, representing 3.50% of the outstanding class based on 25,737,820 shares stated outstanding as of June 30, 2025. The filing notes these holdings are comprised of common stock held by Highlander Partners, L.P., which were formerly held directly by Laurence E. Hirsch, and identifies Mr. Hirsch as sole manager of Highlander Partners GP, LLC. The filing clarifies voting and dispositive powers: Hirsch and Highlander Partners, L.P. report sole voting and dispositive power over 900,000 shares while Highlander Partners GP, LLC reports shared voting and dispositive power over the same amount. The schedule includes a joint filing agreement, an Item 8 statement, and a previously filed power of attorney.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Disclosure shows a passive sub-5% stake of 3.50% by related parties with clear voting/dispositive allocations.

The Schedule 13G/A documents a non-control ownership position totaling 900,000 shares (3.50%) held by closely related reporting persons: Laurence E. Hirsch, Highlander Partners, L.P., and Highlander Partners GP, LLC. The filing explicitly attributes sole voting and dispositive power to Mr. Hirsch and Highlander Partners, L.P., and shared powers to the general partner entity. Because the stake is under 5% and the filing includes the required joint filing agreement and power of attorney reference, this is a routine beneficial ownership disclosure rather than an activist or control-oriented filing. Materiality is limited; the position is transparent and compliant with reporting obligations.

TL;DR: Related-party ownership and governance roles are disclosed; no indication of change-in-control intent.

The filing clarifies the organizational relationships and control roles: Mr. Hirsch is identified as sole manager of the GP entity and prior direct holder of the shares now held by Highlander Partners, L.P. The Schedule includes certifications that the securities were not acquired to influence control, consistent with Rule 13d-1(b) reporting. For governance assessment, the disclosed allocation of sole versus shared voting and dispositive powers helps shareholders understand who can direct voting and disposition. There is no indication in the filing of coordinated group action beyond the joint filing agreement; impact on issuer governance appears negligible given the sub-5% stake.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Comprised of shares of Common Stock held by Highlander Partners, L.P., which shares were formerly held by Laurence E. Hirsch directly. Mr. Hirsch is the sole manager of Highlander Partners GP, LLC, the general partner of Highlander Partners, L.P.


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: Comprised of shares of Common Stock held by Highlander Partners, L.P., of which Highlander Partners GP, LLC is the general partner.


SCHEDULE 13G



Laurence E. Hirsch
Signature:Nicholas Thicksten
Name/Title:Attorney-In-Fact
Date:08/14/2025
Highlander Partners, L.P.
Signature:Chris McRorie
Name/Title:Vice President, General Counsel & Secretary
Date:08/14/2025
Highlander Partners GP, LLC
Signature:Chris McRorie
Name/Title:Vice President, General Counsel & Secretary
Date:08/14/2025
Exhibit Information

Exhibit A. Joint Filing Agreement. Exhibit B. Item 8 Statement. Exhibit C. Power of Attorney. (1) (1) Power of Attorney previously filed as Exhibit A to a Schedule 13G with regard to Spectral AI, Inc. filed with the Securities and Exchange Commission on November 3, 2023 by Laurence E. Hirsch.

FAQ

What stake in Spectral AI, Inc. (MDAIW) is reported in this Schedule 13G/A?

The filing reports beneficial ownership of 900,000 shares, representing 3.50% of common stock based on 25,737,820 shares outstanding as of June 30, 2025.

Who are the reporting persons named on the filing for MDAIW?

The reporting persons are Laurence E. Hirsch, Highlander Partners, L.P., and Highlander Partners GP, LLC.

Does the filing indicate who has voting and dispositive power over the shares?

Yes. Laurence E. Hirsch and Highlander Partners, L.P. report sole voting and dispositive power over 900,000 shares; Highlander Partners GP, LLC reports shared voting and dispositive power over the same shares.

Was the stake filed as aimed at changing or influencing control of the issuer?

No. The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.

Where is the issuer headquartered as stated in the filing?

The filing lists the issuer's principal executive offices at 2515 McKinney Avenue, Suite 1000, Dallas, TX 75201.
Spectral AI Inc

NASDAQ:MDAIW

MDAIW Rankings

MDAIW Latest News

MDAIW Latest SEC Filings

MDAIW Stock Data

11.34M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
DALLAS